MP25-09 SECOND GENERATION OF TEMPORARY IMPLANTABLE NITINOL DEVICE (ITIND) IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS): WHO PROFIT MOST FROM TREATMENT? 2YEAR RESULTS OF THE MT-02-STUDY